Your browser doesn't support javascript.
loading
Lack of antiviral activity of darunavir against SARS-CoV-2.
De Meyer, Sandra; Bojkova, Denisa; Cinatl, Jindrich; Van Damme, Ellen; Buyck, Christophe; Van Loock, Marnix; Woodfall, Brian; Ciesek, Sandra.
Affiliation
  • De Meyer S; Janssen Pharmaceutica NV, Beerse, Belgium. Electronic address: sdmeyer@its.jnj.com.
  • Bojkova D; Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Cinatl J; Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
  • Van Damme E; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Buyck C; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Van Loock M; Janssen Pharmaceutica NV, Beerse, Belgium.
  • Woodfall B; Janssen Biopharma Inc, South San Francisco, CA, USA.
  • Ciesek S; Institute of Medical Virology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany; German Center for Infection Research (DZIF), Frankfurt, Germany.
Int J Infect Dis ; 97: 7-10, 2020 Aug.
Article in En | MEDLINE | ID: mdl-32479865

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Darunavir / Betacoronavirus Limits: Humans Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Darunavir / Betacoronavirus Limits: Humans Language: En Journal: Int J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2020 Document type: Article Country of publication: